# Lithium Carbonate ER

NDC: 42291-496
Generic name: Lithium Carbonate
Labeler / Manufacturer: AvKARE
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20220225

FDA application: ANDA091616

## Active ingredients

- LITHIUM CARBONATE: 450 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"42291-496"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42291-496
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d8ddff4d-2b77-a8f2-e053-2a95a90a5fc0